Chlordiazepoxide Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Chlordiazepoxide Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CHLORDIAZEPOXIDE HYDROCHLORIDE DESCRIPTION







Chlordiazepoxide Hydrochloride

CLINICAL PHARMACOLOGY


Animal Pharmacology:







Effects on Reproduction:



INDICATIONS & USAGE




CHLORDIAZEPOXIDE HYDROCHLORIDE CONTRAINDICATIONS



WARNINGS


PATIENTS SHOULD BE WARNED ACCORDINGLY.
Usage in Pregnancy: An increased risk of congenital malformations associated with the use of minor tranquilizers (chlordiazepoxide, diazepam and meprobamate) during the first trimester of pregnancy has been suggested in several studies. Because use of these drugs is rarely a matter of urgency, their use during this period should almost always be avoided. The possibility that a woman of childbearing potential may be pregnant at the time of institution of therapy should be considered. Patients should be advised that if they become pregnant during therapy or intend to become pregnant they should communicate with their physicians about the desirability of discontinuing the drug.

DRUG ABUSE AND DEPENDENCE

PRECAUTIONS




PEDIATRIC USE

DOSAGE AND ADMINISTRATIONPRECAUTIONS

INFORMATION FOR PATIENTS




CHLORDIAZEPOXIDE HYDROCHLORIDE ADVERSE REACTIONS







DRUG ABUSE AND DEPENDENCE




OVERDOSAGE


CONTRAINDICATIONSWARNINGSPRECAUTIONS

DOSAGE & ADMINISTRATION














HOW SUPPLIED






STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Chlordiazepoxide Hydrochloride

Chlordiazepoxide Hydrochloride

Chlordiazepoxide Hydrochloride

Chlordiazepoxide Hydrochloride CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-800(NDC:43547-253)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORDIAZEPOXIDE 25 mg

Inactive Ingredients

Ingredient Name Strength
STARCH, CORN
lactose monohydrate
talc
METHYLPARABEN
PROPYLPARABEN
POTASSIUM SORBATE
D&C YELLOW NO. 10
FD&C GREEN NO. 3
titanium dioxide
GELATIN

Product Characteristics

Color Size Imprint Code Shape
green 14 mm S235;S CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-800-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA085475 2011-10-31


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.